Participants 45 84 3
children with autism spectrum disorders
Participants 218 302 5
behavioural symptoms of children with autism spectrum disorders (ASD) ages 3-8 years
Participants 312 390 5
Phase 1 involved 65 children with ASD who received one round of DMSA (3 days).
Participants 391 491 4
Participants who had high urinary excretion of toxic metals were selected to continue on to phase 2.
Participants 492 628 4
In phase 2, 49 participants were randomly assigned in a double-blind design to receive an additional 6 rounds of either DMSA or placebo.
